Gut microbiota and their metabolites in cardiovascular disease

Area of Science:

• Microbiology
• Hematology
• Immunology

Background:

• The gut microbiome is linked to diseases like atherosclerosis and arterial thrombosis.
• Gut-derived metabolites predict arterial thrombosis, potentially inducing platelet hyperreactivity.
• Gut commensals influence platelets via serotonin and Von Willebrand factor.

Purpose of the Study:

• To review the prothrombotic effects of the gut microbiome.
• To provide insight into the gut microbiome's influence on thromboembolic disease and hemostasis.

Main Methods:

• Literature review of preclinical and epidemiological studies.
• Focus on gut microbiome's impact on platelet function and coagulation.
• Examination of mechanisms in autoimmune thrombotic disorders like antiphospholipid syndrome.

Main Results:

• Gut microbiome metabolites can increase thrombotic potential.
• Gut commensals influence platelet function and Von Willebrand factor production.
• Gut commensals may contribute to antiphospholipid syndrome pathophysiology.

Conclusions:

• The gut microbiome plays a significant role in prothrombotic processes.
• Understanding these mechanisms is crucial for managing thromboembolic diseases.
• Further research is needed on the gut microbiome's effects on secondary hemostasis.